Elevated TNF-α production by peripheral blood monocytes of weight-losing COPD patients

Irma De Godoy, Michael Donahoe, William Calhoun, Juliet Mancino, Robert M. Rogers

Research output: Contribution to journalArticle

267 Citations (Scopus)

Abstract

The inflammatory cytokines, tumor necrosis factor-alpha (TNF-α) and interleukin-1-beta (IL-1β), have been associated with accelerated metabolism and protein turnover following exogenous administration in normal humans. We hypothesized that these inflammatory cytokines might contribute to the weight-losing process in patients with chronic obstructive pulmonary disease (COPD). COPD patients were identified prospectively as 'weight losers' (WL; n = 10) if they reported > 5% weight loss during the preceding year or as 'weight stable' (W5; n = 10) if their body weight fluctuated ≤ 5%. Age- matched healthy volunteers were selected as the control group (C; n = 13). Monocytes were isolated from a peripheral blood sample, cultured, and exposed to lipopolysaccharide (LPS). The concentration of TNF-α and IL-1β in the monocyte supernatant was measured using a four layer enhanced ELISA. No significant difference in LPS-stimulated IL-1β production was found in the three study populations. However, LPS-stimulated TNF-α production (mean [range] ng/ml) by monocytes was significantly higher in the WL COPD patients (20.2 [6.3 to 44.8]), compared with WS patients (6.9 [1.5 to 16.6]), and C subjects (5.7 [0 to 61.8]). This difference was not maintained at 6 mo follow-up in the absence of ongoing weight loss. Definition of a causal relationship between TNF-α production and weight loss will require further understanding of the relationship between energy metabolism and TNF-α production in these patients.

Original languageEnglish (US)
Pages (from-to)633-637
Number of pages5
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume153
Issue number2
StatePublished - 1996
Externally publishedYes

Fingerprint

Chronic Obstructive Pulmonary Disease
Monocytes
Tumor Necrosis Factor-alpha
Weights and Measures
Interleukin-1beta
Lipopolysaccharides
Weight Loss
Cytokines
Energy Metabolism
Healthy Volunteers
Enzyme-Linked Immunosorbent Assay
Body Weight
Control Groups
Population
Proteins

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Elevated TNF-α production by peripheral blood monocytes of weight-losing COPD patients. / De Godoy, Irma; Donahoe, Michael; Calhoun, William; Mancino, Juliet; Rogers, Robert M.

In: American Journal of Respiratory and Critical Care Medicine, Vol. 153, No. 2, 1996, p. 633-637.

Research output: Contribution to journalArticle

De Godoy, Irma ; Donahoe, Michael ; Calhoun, William ; Mancino, Juliet ; Rogers, Robert M. / Elevated TNF-α production by peripheral blood monocytes of weight-losing COPD patients. In: American Journal of Respiratory and Critical Care Medicine. 1996 ; Vol. 153, No. 2. pp. 633-637.
@article{47dc69a396284c81a55a2c5a4fa7aa15,
title = "Elevated TNF-α production by peripheral blood monocytes of weight-losing COPD patients",
abstract = "The inflammatory cytokines, tumor necrosis factor-alpha (TNF-α) and interleukin-1-beta (IL-1β), have been associated with accelerated metabolism and protein turnover following exogenous administration in normal humans. We hypothesized that these inflammatory cytokines might contribute to the weight-losing process in patients with chronic obstructive pulmonary disease (COPD). COPD patients were identified prospectively as 'weight losers' (WL; n = 10) if they reported > 5{\%} weight loss during the preceding year or as 'weight stable' (W5; n = 10) if their body weight fluctuated ≤ 5{\%}. Age- matched healthy volunteers were selected as the control group (C; n = 13). Monocytes were isolated from a peripheral blood sample, cultured, and exposed to lipopolysaccharide (LPS). The concentration of TNF-α and IL-1β in the monocyte supernatant was measured using a four layer enhanced ELISA. No significant difference in LPS-stimulated IL-1β production was found in the three study populations. However, LPS-stimulated TNF-α production (mean [range] ng/ml) by monocytes was significantly higher in the WL COPD patients (20.2 [6.3 to 44.8]), compared with WS patients (6.9 [1.5 to 16.6]), and C subjects (5.7 [0 to 61.8]). This difference was not maintained at 6 mo follow-up in the absence of ongoing weight loss. Definition of a causal relationship between TNF-α production and weight loss will require further understanding of the relationship between energy metabolism and TNF-α production in these patients.",
author = "{De Godoy}, Irma and Michael Donahoe and William Calhoun and Juliet Mancino and Rogers, {Robert M.}",
year = "1996",
language = "English (US)",
volume = "153",
pages = "633--637",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "2",

}

TY - JOUR

T1 - Elevated TNF-α production by peripheral blood monocytes of weight-losing COPD patients

AU - De Godoy, Irma

AU - Donahoe, Michael

AU - Calhoun, William

AU - Mancino, Juliet

AU - Rogers, Robert M.

PY - 1996

Y1 - 1996

N2 - The inflammatory cytokines, tumor necrosis factor-alpha (TNF-α) and interleukin-1-beta (IL-1β), have been associated with accelerated metabolism and protein turnover following exogenous administration in normal humans. We hypothesized that these inflammatory cytokines might contribute to the weight-losing process in patients with chronic obstructive pulmonary disease (COPD). COPD patients were identified prospectively as 'weight losers' (WL; n = 10) if they reported > 5% weight loss during the preceding year or as 'weight stable' (W5; n = 10) if their body weight fluctuated ≤ 5%. Age- matched healthy volunteers were selected as the control group (C; n = 13). Monocytes were isolated from a peripheral blood sample, cultured, and exposed to lipopolysaccharide (LPS). The concentration of TNF-α and IL-1β in the monocyte supernatant was measured using a four layer enhanced ELISA. No significant difference in LPS-stimulated IL-1β production was found in the three study populations. However, LPS-stimulated TNF-α production (mean [range] ng/ml) by monocytes was significantly higher in the WL COPD patients (20.2 [6.3 to 44.8]), compared with WS patients (6.9 [1.5 to 16.6]), and C subjects (5.7 [0 to 61.8]). This difference was not maintained at 6 mo follow-up in the absence of ongoing weight loss. Definition of a causal relationship between TNF-α production and weight loss will require further understanding of the relationship between energy metabolism and TNF-α production in these patients.

AB - The inflammatory cytokines, tumor necrosis factor-alpha (TNF-α) and interleukin-1-beta (IL-1β), have been associated with accelerated metabolism and protein turnover following exogenous administration in normal humans. We hypothesized that these inflammatory cytokines might contribute to the weight-losing process in patients with chronic obstructive pulmonary disease (COPD). COPD patients were identified prospectively as 'weight losers' (WL; n = 10) if they reported > 5% weight loss during the preceding year or as 'weight stable' (W5; n = 10) if their body weight fluctuated ≤ 5%. Age- matched healthy volunteers were selected as the control group (C; n = 13). Monocytes were isolated from a peripheral blood sample, cultured, and exposed to lipopolysaccharide (LPS). The concentration of TNF-α and IL-1β in the monocyte supernatant was measured using a four layer enhanced ELISA. No significant difference in LPS-stimulated IL-1β production was found in the three study populations. However, LPS-stimulated TNF-α production (mean [range] ng/ml) by monocytes was significantly higher in the WL COPD patients (20.2 [6.3 to 44.8]), compared with WS patients (6.9 [1.5 to 16.6]), and C subjects (5.7 [0 to 61.8]). This difference was not maintained at 6 mo follow-up in the absence of ongoing weight loss. Definition of a causal relationship between TNF-α production and weight loss will require further understanding of the relationship between energy metabolism and TNF-α production in these patients.

UR - http://www.scopus.com/inward/record.url?scp=0029670951&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029670951&partnerID=8YFLogxK

M3 - Article

VL - 153

SP - 633

EP - 637

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 2

ER -